{
  "kind": "framework",
  "value": "drug-development-lifecycle",
  "collectionKey": "slides:framework:drug-development-lifecycle:all-document-kinds:all-producers:all-orientations",
  "filters": {
    "documentKinds": [],
    "sourceTypes": [],
    "orientations": []
  },
  "total": 2,
  "page": 1,
  "pageSize": 24,
  "pageCount": 1,
  "rows": [
    {
      "docId": "019de074-c89a-7228-80c7-3305707f7e50",
      "docSlug": "2a632d1edd5f737186449d0c40369511",
      "documentTitle": "AbCellera | Investor Presentation Deck | 20 slides",
      "authorId": "abcellera",
      "authorName": "AbCellera",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-05-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 5,
      "slideType": "context",
      "function": "establish_context",
      "notes": "The chart illustrates the 'valley of death' in drug development, highlighting the low probability of success (POS) and the long timeline to commercialization.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": "The slide maps investment and risk against standard drug development phases (Discovery, Phase 1-3, Commercial).",
      "slideHref": "/slides/019de074-c89a-7228-80c7-3305707f7e50/5",
      "deckHref": "/decks/019de074-c89a-7228-80c7-3305707f7e50",
      "deckAnchorHref": "/decks/019de074-c89a-7228-80c7-3305707f7e50#slide-5",
      "loopMatches": [
        {
          "to": 5,
          "from": 4,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "d5aef738-c13e-4700-a5e0-144a4530e1cf",
          "evidence": "Slides 4 and 5 imply that current methods are not optimal, setting up the need for AbCellera's solution.",
          "position": 0,
          "objective": "Highlight the need for improved antibody discovery and development.",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.6,
          "description": "Quantify what happens if the audience does nothing"
        },
        {
          "to": 7,
          "from": 3,
          "name": "Golden Circle",
          "slug": "11-golden-circle",
          "bestFor": "Visionary leadership, brand positioning, mission statements",
          "matchId": "ccd08fb1-5266-40b1-a431-23de1500c550",
          "evidence": "Slides 3 and 7 discuss AbCellera's mission and vision, which align with the Golden Circle loop.",
          "position": 1,
          "objective": "Explain why AbCellera's approach is valuable.",
          "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
          "confidence": 0.6,
          "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 5,
          "from": 4,
          "beatId": "ce4c3757-7e42-4174-b40c-9a393c3b6759",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Problem",
          "beatSlug": "sequoia-pitch-problem",
          "evidence": "Slides 4 and 5 discuss the drug development process and the impact of technology on product creation.",
          "position": 0,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de071-e0d6-76fb-ba84-d69d61ac5ee5",
      "docSlug": "1773642d94b9dc79507cf930970e5456",
      "documentTitle": "Certara | Investor Day Presentation Deck | 91 slides",
      "authorId": "certara",
      "authorName": "Certara",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2021-12-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 51,
      "slideType": "transition",
      "function": "transition",
      "notes": "The slide uses a ribbon-like process diagram to show the stages of drug development.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": "The diagram depicts the standard stages of pharmaceutical development.",
      "slideHref": "/slides/019de071-e0d6-76fb-ba84-d69d61ac5ee5/51",
      "deckHref": "/decks/019de071-e0d6-76fb-ba84-d69d61ac5ee5",
      "deckAnchorHref": "/decks/019de071-e0d6-76fb-ba84-d69d61ac5ee5#slide-51",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    }
  ]
}